Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Erasca Inc. Common Stock (ERAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Erasca Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Erasca Inc. Common Stock trades at $15.57 (market cap $4.95B). The key difference: Definium Therapeutics Inc. Common Shares and Erasca Inc. Common Stock are close in size by market cap, and Erasca Inc. Common Stock is more actively traded (3,834,689 versus 1,966,636). Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Erasca Inc. Common Stock for 0 Days on average.
| DFTX | ERAS | |
|---|---|---|
Market Cap | $4.71B | $4.95B |
Volume | 1,966,636 | 3,834,689 |
Sector | Health | Health |
52-Week High | $48.45 | $22.47 |
52-Week Low | $10.68 | $2.20 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $4.72B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Erasca Inc. Common Stock
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →
